Physician

Kartik Konduri, MD

According to 2025 Medicare claims, Kartik Konduri, MD (NPI: 1417995499) practices medical oncology in the Dallas-Plano-Irving, TX market, with the plurality of this provider's patient population coming from Dallas, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1003083445; TIN: 752131429) and primary practice location at 75246-2012.

Konduri's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 673 traditional Medicare patients, billed 130,366 HCPCS/CPT codes, and received $2,551,000 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 608 prescription claims across 121 beneficiaries totaling $3,316,336 in drug costs, led by Tagrisso (Osimertinib Mesylate). DME data shows 27 claims. Open Payments data shows 61 records totaling $374,399. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $700,531 to $2,551,000. Similarly, Part D prescription costs have risen steadily, from $479,487 to $3,316,336. In contrast, DME billing represents a smaller volume and moved from a higher plateau to a lower plateau, from $3,075 to $1,825.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	386	94,844	$700,531
2016	481	76,265	$896,632
2017	535	74,423	$1,062,215
2018	590	83,251	$1,273,929
2019	579	90,496	$1,420,644
2020	485	63,382	$1,069,292
2021	538	73,499	$1,238,223
2022	603	95,164	$1,691,607
2023	636	153,672	$2,753,207
2024	673	130,366	$2,551,000

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	91	433	$479,487
2016	88	460	$565,795
2017	102	519	$997,946
2018	98	411	$806,175
2019	103	450	$627,793
2020	93	408	$919,804
2021	87	358	$723,183
2022	82	366	$1,267,151
2023	97	459	$1,524,305
2024	121	608	$3,316,336

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	73	$4,718
2016	N/R	24	$2,542
2017	N/R	92	$6,367
2018	N/R	81	$4,815
2019	N/R	34	$1,391
2020	N/R	34	$1,354
2021	N/R	N/R	N/R
2022	N/R	18	$1,251
2023	N/R	12	$849
2024	N/R	27	$1,547

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	215	317	$100
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	183	673	$98
80053	Blood test, comprehensive group of blood chemicals	210	816	$10
36415	Insertion of needle into vein for collection of blood sample	208	880	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	205	805	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tagrisso	Osimertinib Mesylate	84	2,488	$1,393,850
Tabrecta	Capmatinib Hydrochloride	28	784	$320,725
Lumakras	Sotorasib	13	390	$282,744
Mekinist	Trametinib Dimethyl Sulfoxide	22	660	$276,727
Tafinlar	Dabrafenib Mesylate	18	540	$240,531

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	16	$1,165
K0738	Portable gaseous oxygen system, rental; home compressor used to fill portable oxygen cylinders; includes portable containers, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	11	$382

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$21,537	JAZZ PHARMACEUTICALS INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	44	$352,861	Mirati Therapeutics, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kartik Konduri, MD?

Tedicare shows public-source Medicare data for Kartik Konduri, MD (NPI 1417995499), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kartik Konduri, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kartik Konduri, MD?

Kartik Konduri, MD is linked to TEXAS ONCOLOGY PA (billing NPI 1003083445) in the available physician profile data.

Does Kartik Konduri, MD have Open Payments data?

Kartik Konduri, MD has 61 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.